Levipil 1g Tablet contains Levetiracetam 1000mg, an antiepileptic medication primarily indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit burst firing and reduce seizure propagation. This mechanism contributes to its efficacy in controlling various seizure types. Levipil is typically prescribed as adjunctive therapy in adults and pediatric patients over 4 years of age but may also be used as monotherapy depending on clinical judgment. The tablet is administered orally, with dosage individualized based on patient response, renal function, and tolerability. Common adverse effects include somnolence, dizziness, headache, and fatigue, while serious adverse reactions are rare but may involve behavioral changes or hypersensitivity. Caution is advised in patients with renal impairment, and dose adjustment is recommended accordingly. Levipil should be used under strict medical supervision, with regular monitoring to optimize therapeutic outcomes and minimize potential side effects. It is essential to adhere to prescribed dosing and not discontinue therapy abruptly to prevent seizure exacerbation.